Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
-
2010/12/15
-
Details
-
Personal Author:Christensen BC ; Gee GV ; Houseman EA ; Ivaldi GP ; Kelsey KT ; Koestler DC ; Marsit CJ ; Resnick MB ; Sugarbaker DJ ; Ugolini D
-
Description:Malignant pleural mesothelioma (MPM) is a rapidly fatal disease whose diagnosis, particularly through less invasive techniques such as analysis of pleural effusion, can be challenging. Currently, a commercially available diagnostic test based on microRNA (miRNA) expression patterns is purported to distinguish between mesothelioma and lung adenocarcinoma. Yet, the biological basis of this technology has not been reported in the literature, and little research has been aimed at determining how differential miRNA expression contributes to the differences in pathogenesis between these diseases, both of which can be caused by asbestos exposure. We sought to illuminate the molecular differences between mesothelioma and lung adenocarcinoma by using miRNA microarrays to identify patterns in the most differentially expressed miRNAs. From this, we identified a panel of miRNAs, including members of the miR-200 gene family, that were all downregulated in MPM compared to lung adenocarcinoma. Using the more sensitive detection method of quantitative RT-PCR on an independent series of tumors, we validated the specificity of these alterations in 100 MPMs and 32 lung adenocarcinomas. Statistical analysis reveals that these miRNAs exceed the current recommendations for biomarkers and could greatly aid in the differential diagnosis. Further examination led us to predict that they act as redundant regulators of wnt signaling and suggests a role for this pathway in tumor progression. This research points to novel approaches using miRNAs whose decreased expression is unique to mesothelioma as potentially suitable for rapid diagnosis and reveals prospective new targets for the treatment of this deadly disease. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0020-7136
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:127
-
Issue:12
-
NIOSHTIC Number:nn:20038753
-
Citation:Int J Cancer 2010 Dec; 127(12):2859-2869
-
Contact Point Address:Carmen J. Marsit, Department of Pathology and Laboratory Medicine, Brown University, Box G-E537, Providence, RI 02912, USA
-
Email:carmen_marsit@brown.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2011
-
NORA Priority Area:
-
Performing Organization:University of Pittsburgh at Pittsburgh
-
Peer Reviewed:True
-
Start Date:20060901
-
Source Full Name:International Journal of Cancer
-
End Date:20260831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:679ae28110ecc17f996f5b9f09f58365bd87a74b4da15fa8e5e203d206a6c234127eb01bbbb71dc53bb6a9a0a0c48949301886137d3a561d3d008c9c8f9d2dae
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like